A Randomized, Multicenter Trial of Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated Methicillin-resistant Staphylococcus Aureus Bacteremia.

Trial Profile

A Randomized, Multicenter Trial of Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated Methicillin-resistant Staphylococcus Aureus Bacteremia.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 May 2014

At a glance

  • Drugs Daptomycin (Primary) ; Vancomycin
  • Indications Methicillin-resistant Staphylococcus aureus infections; Nosocomial infections
  • Focus Therapeutic Use
  • Acronyms DAVASAB
  • Most Recent Events

    • 23 Aug 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Jun 2012 Actual initiation date (1 May 2012) added as reported by ClinicalTrials.gov.
    • 08 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top